Immunotherapy Stocks List

Symbol Grade Name % Change
CLDX B Celldex Therapeutics, Inc. 0.00
FBIO F Fortress Biotech, Inc. 0.00
CDMO A Avid Bioservices, Inc. 0.00
CVM F Cel-Sci Corporation 0.00
BTX D Brooklyn ImmunoTherapeutics, Inc. 1.27
IMUX F Immunic, Inc. -0.98
GNCA F Genocea Biosciences, Inc. 0.00
ATNM F Actinium Pharmaceuticals, Inc. 0.00
ENLV F Enlivex Therapeutics Ltd. 0.00
DBVT C DBV Technologies S.A. 0.00
APTO F Aptose Biosciences, Inc. 0.00
BLCM F Bellicum Pharmaceuticals, Inc. 0.00
IOVA C Iovance Biotherapeutics, Inc. 0.00
CDTX F Cidara Therapeutics, Inc. 0.00
ADAP F Adaptimmune Therapeutics plc 0.00
ONCS F OncoSec Medical Incorporated -2.93
CLBS F Caladrius Biosciences, Inc. 0.00
ALPN D Alpine Immune Sciences, Inc. 0.00
IBRX F ImmunityBio, Inc. 0.00
PDSB D PDS Biotechnology Corporation 0.00
CNCR D Loncar Cancer Immunotherapy ETF 0.00
SELB F Selecta Biosciences, Inc. 0.00
MRKR D Marker Therapeutics, Inc. 0.00
JNCE F Jounce Therapeutics, Inc. 0.00
URGN F UroGen Pharma Ltd. 0.00
ARGX B argenx SE 0.00
IMRN F Immuron Limited 0.00
MBIO F Mustang Bio, Inc. 0.00
FBIOP B Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock 0.00
CDMOP D Avid Bioservices, Inc. - 10.50% Series E Convertible Preferred Stock 0.00
SURF F Surface Oncology, Inc. 0.00
IMV F IMV Inc. 0.00
REPL F Replimune Group, Inc. 0.00
ARDS F Aridis Pharmaceuticals Inc. 0.00
GRTS F Gritstone Oncology, Inc. 0.00
AVCO F Avalon GloboCare Corp. 0.00
INMB B INmune Bio Inc. -3.89
HARP F Harpoon Therapeutics, Inc. 0.00
TCRR F TCR2 Therapeutics Inc. 0.00
DTIL D Precision BioSciences, Inc. 0.00
NXTC F NextCure, Inc. 0.00
LCTX C Lineage Cell Therapeutics, Inc. 0.00
IPHA D Innate Pharma S.A. 0.00
THMO F ThermoGenesis Holdings, Inc. -1.26
ORIC F Oric Pharmaceuticals, Inc. 0.29
ADTX F ADiTx Therapeutics, Inc. 0.00
IMTX B Immatics N.V. 0.00
NKTX C Nkarta, Inc. 0.00
PAND A Pandion Therapeutics Inc. 0.00
CMPI F Checkmate Pharmaceuticals, Inc. 0.00
HGEN D Humanigen, Inc. 0.00
GLSI B Greenwich LifeSciences, Inc. 0.00
ONCR F Oncorus, Inc. 0.00
NBTX F Nanobiotix S.A. 0.00
SNSE F Sensei Biotherapeutics, Inc. 0.00
EVAX F Evaxion Biotech A/S 0.00
IMCR F Immunocore Holdings plc 0.00
ADAG B Adagene Inc. 0.00
NEXI F NexImmune, Inc. 0.00
BCTX D BriaCell Therapeutics Corp. 0.00
CNTB A Connect Biopharma Holdings Limited 0.00
CNTA B Centessa Pharmaceuticals plc 0.00
ABOS F Acumen Pharmaceuticals, Inc. 0.00
View As Page of Charts


Recent Signals

Date Stock Signal Type
2021-07-23 ABOS New 52 Week Closing Low Bearish
2021-07-23 ABOS New 52 Week Low Weakness
2021-07-23 ABOS Narrow Range Bar Range Contraction
2021-07-23 ABOS Hot IPO Pullback Bullish Swing Setup
2021-07-23 ADAG Volume Surge Other
2021-07-23 ADAP MACD Bearish Signal Line Cross Bearish
2021-07-23 ADAP New 52 Week Closing Low Bearish
2021-07-23 ADTX Wide Range Bar Range Expansion
2021-07-23 ADTX Shooting Star Candlestick Bearish
2021-07-23 ADTX Reversal New Lows Setup Bearish Swing Setup
2021-07-23 ADTX Expansion Pivot Sell Setup Bearish Swing Setup
2021-07-23 ADTX 20 DMA Resistance Bearish
2021-07-23 ADTX 200 DMA Resistance Bearish
2021-07-23 ADTX Volume Surge Other
2021-07-23 ADTX 50 DMA Resistance Bearish
2021-07-23 ALPN Narrow Range Bar Range Contraction
2021-07-23 ALPN NR7 Range Contraction
2021-07-23 APTO New 52 Week Closing Low Bearish
2021-07-23 APTO New 52 Week Low Weakness
2021-07-23 ARDS 20 DMA Resistance Bearish
2021-07-23 ARDS 200 DMA Resistance Bearish
2021-07-23 ARDS Shooting Star Candlestick Bearish
2021-07-23 ARDS New Uptrend Bullish
2021-07-23 ARDS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-07-23 ARDS Volume Surge Other
2021-07-23 ARDS Wide Range Bar Range Expansion
2021-07-23 ARDS 50 DMA Resistance Bearish
2021-07-23 ARGX NR7 Range Contraction
2021-07-23 ARGX Bollinger Band Squeeze Range Contraction
2021-07-23 ARGX Slingshot Bullish Bullish Swing Setup
2021-07-23 AVCO Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-07-23 BCTX NR7 Range Contraction
2021-07-23 BCTX Narrow Range Bar Range Contraction
2021-07-23 BCTX Lizard Bullish Bullish Day Trade Setup
2021-07-23 BCTX Hammer Candlestick Bullish
2021-07-23 BCTX Doji - Bullish? Reversal
2021-07-23 BLCM Narrow Range Bar Range Contraction
2021-07-23 BLCM NR7 Range Contraction
2021-07-23 CDMO Bollinger Band Squeeze Range Contraction
2021-07-23 CDMO Crossed Above 20 DMA Bullish
2021-07-23 CDTX Stochastic Reached Oversold Weakness
2021-07-23 CDTX New 52 Week Closing Low Bearish
2021-07-23 CNCR Fell Below 50 DMA Bearish
2021-07-23 CNTB New 52 Week High Strength
2021-07-23 CNTB New 52 Week Closing High Bullish
2021-07-23 CVM Narrow Range Bar Range Contraction
2021-07-23 DBVT 20 DMA Resistance Bearish
2021-07-23 DBVT Spinning Top Other
2021-07-23 DTIL Stochastic Reached Oversold Weakness
2021-07-23 ENLV NR7 Range Contraction
2021-07-23 EVAX Stochastic Reached Oversold Weakness
2021-07-23 FBIO NR7 Range Contraction
2021-07-23 FBIO Stochastic Reached Oversold Weakness
2021-07-23 FBIOP 50 DMA Resistance Bearish
2021-07-23 GLSI 20 DMA Resistance Bearish
2021-07-23 GNCA MACD Bearish Signal Line Cross Bearish
2021-07-23 GNCA Lizard Bullish Bullish Day Trade Setup
2021-07-23 GNCA Narrow Range Bar Range Contraction
2021-07-23 GNCA NR7 Range Contraction
2021-07-23 GNCA Hammer Candlestick Bullish
2021-07-23 HARP MACD Bearish Signal Line Cross Bearish
2021-07-23 HARP Jack-in-the-Box Bearish Bearish Swing Setup
2021-07-23 HARP Calm After Storm Range Contraction
2021-07-23 HARP Stochastic Reached Oversold Weakness
2021-07-23 HARP Lower Bollinger Band Walk Weakness
2021-07-23 HGEN 200 DMA Support Bullish
2021-07-23 HGEN 20 DMA Resistance Bearish
2021-07-23 HGEN Bollinger Band Squeeze Range Contraction
2021-07-23 IMCR Narrow Range Bar Range Contraction
2021-07-23 IMCR NR7 Range Contraction
2021-07-23 IMTX Upper Bollinger Band Walk Strength
2021-07-23 IMTX Bollinger Band Squeeze Range Contraction
2021-07-23 IMUX Calm After Storm Range Contraction
2021-07-23 IMUX New 52 Week Closing Low Bearish
2021-07-23 IMUX New 52 Week Low Weakness
2021-07-23 IMUX New Downtrend Bearish
2021-07-23 IMV Pocket Pivot Bullish Swing Setup
2021-07-23 IMV Wide Range Bar Range Expansion
2021-07-23 IMV Volume Surge Other
2021-07-23 IMV 20 DMA Resistance Bearish
2021-07-23 INMB 20 DMA Support Bullish
2021-07-23 IOVA NR7-2 Range Contraction
2021-07-23 IOVA 50 DMA Support Bullish
2021-07-23 IOVA NR7 Range Contraction
2021-07-23 IPHA Narrow Range Bar Range Contraction
2021-07-23 LCTX Fell Below 50 DMA Bearish
2021-07-23 LCTX NR7 Range Contraction
2021-07-23 MBIO New Downtrend Bearish
2021-07-23 MBIO Expansion Breakdown Bearish Swing Setup
2021-07-23 MRKR 200 DMA Support Bullish
2021-07-23 NBTX MACD Bearish Signal Line Cross Bearish
2021-07-23 NBTX Narrow Range Bar Range Contraction
2021-07-23 NBTX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-07-23 NEXI New 52 Week Low Weakness
2021-07-23 NEXI New 52 Week Closing Low Bearish
2021-07-23 NEXI Expansion Breakdown Bearish Swing Setup
2021-07-23 NKTX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-07-23 NKTX 20 DMA Support Bullish
2021-07-23 NKTX 180 Bullish Setup Bullish Swing Setup
2021-07-23 NXTC New 52 Week Low Weakness
2021-07-23 NXTC New 52 Week Closing Low Bearish
2021-07-23 ONCR NR7-2 Range Contraction
2021-07-23 ONCR NR7 Range Contraction
2021-07-23 ONCS New 52 Week Low Weakness
2021-07-23 ONCS New 52 Week Closing Low Bearish
2021-07-23 ORIC Stochastic Reached Oversold Weakness
2021-07-23 ORIC New 52 Week Low Weakness
2021-07-23 ORIC New 52 Week Closing Low Bearish
2021-07-23 PDSB Fell Below 50 DMA Bearish
2021-07-23 SELB Calm After Storm Range Contraction
2021-07-23 SNSE MACD Bullish Signal Line Cross Bullish
2021-07-23 SNSE 1,2,3 Retracement Bearish Bearish Swing Setup
2021-07-23 SNSE Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-07-23 TCRR New 52 Week Closing Low Bearish
2021-07-23 TCRR New 52 Week Low Weakness
2021-07-23 URGN Fell Below 20 DMA Bearish
2021-07-23 URGN Bearish Engulfing Bearish

Immunotherapy Stocks Recent News

Date Stock Title
Jul 26 ARDS Aridis Pharmaceuticals' COVID mAb Ranks Among the Top 5 Most Potent COVID-19 mAbs Evaluated by the Coronavirus Immunotherapeutics Consortium (CoVIC)
Jul 25 INMB INmune Bio (NASDAQ:INMB) Is In A Good Position To Deliver On Growth Plans
Jul 24 CLDX How Good Were Celldex Therapeutics' Latest Clinical Results?
Jul 24 ALPN Read This Before Selling Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares
Jul 23 ABOS Landmark Infrastructure, CVRx See Activist Action
Jul 23 BTX Brooklyn Immuno Reports Inducement Grants
Jul 23 IMV IMV posts biggest one-day gain in more than a year after bullish call from Wells Fargo
Jul 23 INMB Why Annovis Stock Is Bucking The Trend In Alzheimer's — And Two Others To Watch
Jul 22 GNCA Genocea to Host Second Quarter 2021 Corporate Update Conference Call & Webcast
Jul 22 ARGX ICER uncertain about cost-effectiveness of argenx's efgartigimod for myasthenia gravis
Jul 22 INMB INmune Bio acquires LUMICKS' z-Movi Cell Avidity Analyzer
Jul 22 INMB INmune Bio acquires LUMICKS' z-Movi® Cell Avidity Analyzer to accelerate the development of its NK cell platform for cancer treatments
Jul 22 HGEN Humanigen’s partner in South Korea cleared to start early-stage trial for COVID-19 therapy
Jul 22 HGEN Humanigen’s Partner in South Korea Receives Ministry of Food and Drug Safety (MFDS) Approval to Conduct Phase 1 Study of Lenzilumab
Jul 22 ADAG Adagene To Test Its Anti-CTLA-4 Monoclonal Antibodies In Combination With Keytruda In Solid Tumors
Jul 22 CLDX Celldex rises with bullish call from Guggenheim; potential of lead asset cited
Jul 22 ADAG Merck and Adagene ink trial collaboration and supply agreement
Jul 22 CLBS Caladrius Biosciences to Present at Zooming with LD
Jul 22 ADAG Adagene Announces Clinical Trial Collaboration With Merck to Advance Two Anti-CTLA-4 Monoclonal Antibody Programs (ADG116 and ADG126) in Combination Therapy with KEYTRUDA® (pembrolizumab)
Jul 22 ARGX argenx to Report Half Year 2021 Financial Results and Second Quarter Business Update on July 29, 2021

Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.

In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.

More about Immunotherapy
Browse All Tags